All patients (n = 182) | Active participants (n = 18) | Non-active participants (n = 164) | P | |
---|---|---|---|---|
Age (years) | 64.0 ± 10.7 | 66.2 ± 9.8 | 63.7 ± 10.8 | 0.35 |
Gender (% male) | 85.2 | 83.3 | 85.4 | 0.73 |
Height (m) | 1.63 ± 0.08 | 1.64 ± 0.09 | 1.63 ± 0.08 | 0.58 |
Weight (kg) | 64.1 ± 11.8 | 65.9 ± 14.4 | 63.9 ± 11.5 | 0.51 |
Body mass index (kg/m2) | 23.9 ± 3.4 | 24.3 ± 4.4 | 23.9 ± 3.2 | 0.61 |
Unemployed (%) | 47.8 | 61.1 | 46.3 | 0.32 |
Intervention for IHD | 0.54 | |||
CABG (%) | 20.3 | 11.1 | 21.3 | |
PCI (%) | 79.7 | 88.9 | 78.7 | |
Comorbidities (%) | ||||
Cerebrovascular disease | 8.8 | 11.1 | 8.5 | 0.66 |
Orthopedic disorder | 19.9 | 23.5 | 19.5 | 0.75 |
Diabetes mellitus | 40.1 | 38.9 | 40.2 | 1.00 |
Smoking (%) | 0.17 | |||
Current | 35.9 | 17.6 | 37.8 | |
Former | 35.4 | 53.0 | 33.5 | |
Never | 28.7 | 29.4 | 28.7 | |
Laboratory data | ||||
Hemoglobin (g/dL) | 12.9 ± 1.64 | 12.7 ± 1.36 | 13.0 ± 1.70 | 0.49 |
Peak creatine kinase (IU/L) | 2367 ± 2536 | 2719 ± 3102 | 2330 ± 2479 | 0.55 |
Albumin (g/dL) | 3.94 ± 0.42 | 3.91 ± 0.45 | 3.94 ± 0.41 | 0.74 |
High-sensitive CRP (mg/dL) | 0.76 ± 1.24 | 0.43 ± 0.44 | 0.79 ± 1.29 | 0.25 |
Left ventricular ejection fraction (%) | 51.2 ± 13.7 | 50.0 ± 13.9 | 51.3 ± 13.7 | 0.70 |
Ankle-brachial index | 1.08 ± 0.12 | 1.09 ± 0.14 | 1.08 ± 0.12 | 0.65 |
Duration of hospital stay (days) | 25.9 ± 16.4 | 22.9 ± 6.73 | 26.3 ± 17.1 | 0.41 |
eGFR (mL/min/1.73 m2) | ||||
At baseline (hospital discharge) | 61.6 ± 19.2 | 58.8 ± 20.6 | 61.9 ± 19.1 | 0.52 |
At 3 months | 59.6 ± 20.5 | 61.8 ± 17.2 | 59.4 ± 20.9 | 0.68 |
Δ eGFR (mL/min/1.73 m2) | −0.97 ± 13.9 | 4.77 ± 19.7 | −1.53 ± 13.2 | 0.12 |
6-min walk distance (m) | ||||
At baseline (hospital discharge) | 469.5 ± 99.8 | 451.8 ± 85.3 | 471.5 ± 101.3 | 0.43 |
At 3 months | 516.5 ± 110.2 | 511.9 ± 88.1 | 517.0 ± 112.6 | 0.86 |
Δ 6-min walk distance (m) | 46.9 ± 62.4 | 60.1 ± 37.8 | 45.5 ± 64.5 | 0.35 |